Kurma Partners Healthcare Acquisition | M&A Deal

Kurma Partners has completed the acquisition of BioFund IV, a healthcare services other business in France, for €215m. Kurma Partners acquisitions focus on funding life sciences and healthcare services platforms, supporting portfolio companies across clinical and commercial development. The healthcare M&A strategy behind this private equity acquisition aims to scale operators through a platform acquisition approach in European markets, including Paris-based investment activity. The closed platform acquisition follows Kurma Partners’ fourth Biofund, raised by the Eurazeo-owned healthcare VC investor, with a €250m target not fully reached.